Willis Towers Watson plc — FY 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. Although the request identifies 2022 Q4, this is an annual filing; it reports full-year results, not a standalone fourth-quarter earnings summary. WTW is a global advisory, insurance broking and solutions company. On January 1, 2022, it reorganized into Health, Wealth & Career (HWC) and Risk & Broking (R&B). The audited financial statements received an unqualified opinion, and management and the auditor concluded internal control over financial reporting was effective.
Financial results and liquidity
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $8.866 billion | $8.998 billion |
| Income from continuing operations | $1.064 billion | $2.156 billion |
| Net income attributable to WTW | $1.009 billion | $4.222 billion |
| Diluted EPS from continuing operations | $9.34 | $16.63 |
| Operating cash flow | $812 million | $2.061 billion |
| Free cash flow (non-GAAP) | $674 million | $1.913 billion |
- Revenue declined 1% as reported, reflecting a $335 million unfavorable currency impact; organic revenue grew 4%.
- GAAP operating income was $1.178 billion, or 13.3% of revenue, versus $2.202 billion, or 24.5%, in 2021. Adjusted operating income was $1.851 billion and adjusted margin was 20.9%, compared with $1.791 billion and 19.9%. Adjusted EBITDA was $2.387 billion, broadly level with $2.394 billion.
- Adjusted diluted EPS increased to $13.41 from $11.60, primarily reflecting the lower share count after repurchases. These are non-GAAP measures and should be read alongside GAAP results.
- At year-end, cash and cash equivalents were $1.262 billion, total debt was $4.721 billion, and the capitalization ratio was 32.0% versus 25.7%. The $1.5 billion revolving credit facility was undrawn; management said available liquidity was sufficient for the next 12 months. Cash, cash equivalents and restricted cash totaled $4.721 billion, including fiduciary funds unavailable for corporate use.
- Operating cash flow fell partly because of the prior-year $1 billion Aon termination payment, related 2022 tax payments, working-capital outflows and the loss of Willis Re cash generation. Financing included $3.5 billion of share repurchases and $369 million of dividends. WTW repurchased 15.7 million shares at an average $224.42.
Segments and changes versus prior year
- HWC: Segment revenue was $5.287 billion versus $5.268 billion; organic growth was 3%. Management cited Medicare Advantage sales and an expanded client base, health portfolio growth, and demand for Career advisory and benchmarking. Wealth organic growth was flat.
- R&B: Segment revenue was $3.460 billion versus $3.564 billion; organic growth was 3%. As-reported revenue was affected by currency and divestitures. Organic growth reflected CRB activity across regions, especially Aerospace and Construction, and increased ICT software sales and advisory work. Segment operating income was $734 million versus $835 million.
- The sharp decline in reported net income and GAAP operating income largely reflects unusual prior-year items: the $1 billion Aon termination receipt and substantial gains from discontinued operations and disposals. FY 2021 included $2.080 billion of discontinued-operations income; FY 2022 recorded a $40 million discontinued-operations loss. Adjusted comparisons provide a different view of ongoing performance.
Outlook, commentary and risks
- WTW expects its three-year Transformation program to deliver more than $360 million of annual cost savings by the end of 2024. Estimated cumulative costs are $630 million and capital expenditures about $270 million, for a total investment of $900 million. Management cautions that savings and execution are not assured.
- The transfer of the Russian subsidiaries to local management was completed in 2022. WTW estimated an annualized revenue impact of about $120 million; the business had operating margins more than twice the enterprise-level margin. The divestiture generated a $57 million loss and $81 million of asset impairments, and management expects lost profits to weigh on earnings, margins and cash flow.
- The Willis Re sale to Gallagher was completed, including deferred closings. The transaction had $3.25 billion of upfront consideration and a potential earnout of up to $750 million in 2025, subject to conditions; WTW had not recognized an earnout receivable. Transition-service obligations and retained liabilities remain areas to monitor.
- Management reported modest overall insurance-market price increases. It also warned that talent competition, inflation, foreign-exchange movements, recession risk, geopolitical tensions, COVID-related disruption, technology and cybersecurity risks, and regulatory changes could pressure growth or margins. Management said staff departures had made R&B growth in 2022 meaningfully slower than some competitors and could affect 2023 performance.
- No specific 2023 revenue or earnings guidance is provided in the supplied filing text. The company forecast 2023 capital expenditures of $225 million to $250 million.
- WTW disclosed ongoing regulatory inquiries, including civil investigations concerning alleged exchanges of commercially sensitive information in aviation and aerospace insurance and reinsurance broking. It also reported a voluntary OFAC self-disclosure concerning indirect transactions involving a reinsurance pool that included Iranian carriers in some years; WTW said it did not transact directly with those carriers and does not intend future dealings with them.
- Claims and litigation are ordinary-course risks; the filing says an adverse resolution could materially affect a particular period. The auditor identified the errors-and-omissions reserve, especially incurred-but-not-reported claims, as a critical audit matter. Recorded provisions for claims, lawsuits and other proceedings were $296 million at year-end.
Important facts for investors to verify
- Reconcile GAAP and adjusted results, particularly the impact of the Aon payment, Willis Re and other divestiture gains, and transformation costs.
- Track whether the Transformation program achieves stated savings relative to its $900 million investment and timeline.
- Assess the continuing earnings and cash-flow impact of the Russia exit and the terms, transition costs and potential earnout from the Willis Re sale.
- Monitor cash conversion, working capital, upcoming debt maturities, repurchases and dividends; fiduciary funds are not available for general corporate purposes.
- Review developments in the disclosed regulatory investigations, OFAC matter, and errors-and-omissions claims and reserves.